Clinical Trials
2 trialsNCT01486277 2016-11-03
A Study of the Histone Deacetylase Inhibitor (HDACi) Quisinostat (JNJ-26481585) in Patients With Previously Treated Stage Ib-IVa Cutaneous T-cell Lymphoma
Janssen Research & Development, LLC
Phase 2 Completed
NCT00677105 2012-09-17
A Safety and Dose-finding Study of JNJ-26481585 for Patients With Advanced Solid Malignancies and Lymphoma.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase 1 Completed